Literature DB >> 26722567

Pathological analysis of collision (double primary) cancer in the upper digestive tract concomitant with gastric stromal tumor: a case report.

Xun Sun1, Yabin Zou1, Yueming Hao2, Hongjing Cheng2, Changli Zhou2, Xiangwei Meng2.   

Abstract

Carcinoma of the esophagus and cardiac cancer are common malignancies, while multiple primary cancers in the esophagus and cardia is rarely encountered and easily misdiagnosed. Multiple primary cancers mean the same organs (tissues) or different organs (tissues) have two or more than two primary malignant tumors at the same time or in sequence in the same individual. The case below of two independent primary lesions is double primary carcinoma which meets the diagnosis standard of multiple primary cancers. Gastrointestinal stromal tumor is the most common stromal tumor, which is usually considered as originating from Cajal cells in the gastrointestinal tract or mesenchymal stem cells with the mutation of KIT or PDGFRA gene. Study on stromal tumor with digestive tract cancer is less both at home and abroad, while double primary carcinoma with stromal tumor is rare, which has not been reported at present. Although scholars have different viewpoints on the prognosis, but the full understanding of this disease can be as a warning for the future work and to avoid misdiagnosis.

Entities:  

Keywords:  Squamous cell carcinoma; double primary carcinoma; histopathology; immunochemistry; mucinous adenocarcinoma; stromal tumor

Mesh:

Year:  2015        PMID: 26722567      PMCID: PMC4680512     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  8 in total

1.  Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome.

Authors:  Shoji Natsugoe; Masataka Matsumoto; Hiroshi Okumura; Sumiya Ishigami; Yoshikazu Uenosono; Tetsuhiro Owaki; Sonshin Takao; Takashi Aikou
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

Review 2.  KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).

Authors:  Jerzy Lasota; Markku Miettinen
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 3.  Occurrence of other malignancies in patients with gastrointestinal stromal tumors.

Authors:  Abbas Agaimy; Peter H Wünsch; Leslie H Sobin; Jerzy Lasota; Markku Miettinen
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

4.  [Clinicopathologic features and prognostic factors of gastric gastrointestinal stromal tumor with synchronous gastric cancer].

Authors:  Xiu-li Liu; Jia-bin Wang; Chang-ming Huang; Chao-hui Zheng; Ping Li; Jian-wei Xie; Jian-xian Lin
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2012-03

5.  Clinicopathological features of esophageal cancer simultaneously associated with gastric cancer.

Authors:  Y Hamabe; H Ikuta; Y Nakamura; K Kawasaki; M Yamamoto
Journal:  J Surg Oncol       Date:  1998-07       Impact factor: 3.454

6.  Synchronous gastric gastrointestinal stromal tumor and signet-ring cell adenocarcinoma: a case report.

Authors:  Fang-Yi Lee; Yee-Jee Jan; John Wang; Cheng-Chan Yu; Cheng-Chung Wu
Journal:  Int J Surg Pathol       Date:  2007-10       Impact factor: 1.271

7.  Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

Authors:  Heikki Joensuu
Journal:  Hum Pathol       Date:  2008-10       Impact factor: 3.466

8.  Esophageal carcinoma simultaneously associated with gastric carcinoma: analysis of clinicopathologic features and treatments.

Authors:  H Kato; Y Tachimori; H Watanabe; S Mizobuchi; H Igaki; H Yamaguchi; A Ochiai
Journal:  J Surg Oncol       Date:  1994-06       Impact factor: 3.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.